W140 HBr

CAS No. 1246817-25-3

W140 HBr( —— )

Catalog No. M35378 CAS No. 1246817-25-3

[(3S)-3-amino-4-(3-hexylanilino)-4-oxobutyl]phosphonic acid;hydrobromide is a S1P1 antagonist with Ki of 2.84 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 283 In Stock
2MG 166 In Stock
5MG 255 In Stock
10MG 375 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1051 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    W140 HBr
  • Note
    Research use only, not for human use.
  • Brief Description
    [(3S)-3-amino-4-(3-hexylanilino)-4-oxobutyl]phosphonic acid;hydrobromide is a S1P1 antagonist with Ki of 2.84 μM.
  • Description
    W140 hydrobromide is a S1P1 antagonist with the Ki of 2.84 μM, and can enhanceof capillary leakage and restoration of lymphocyte egress.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    S1P Receptor
  • Recptor
    S1P Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1246817-25-3
  • Formula Weight
    423.28
  • Molecular Formula
    C16H28BrN2O4P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C([C@H](CCP(=O)(O)O)N)=O)C1=CC(CCCCCC)=CC=C1.Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sanna MG, et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol. 2006;2(8):434-441.?
molnova catalog
related products
  • PF-543 hydrochloride

    PF-543 inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.

  • SEW2871

    Sphingosine-1-phosphate receptor 1 agonist SEW2871 prolongs heterotopic heart allograft survival in mice.

  • GLPG2938

    GLPG2938 is a potent and selective antagonist of S1P2.